FDA approves first test for Zika in human blood

FDA approves first test for zika in human blood

(HealthDay)—The first test to detect the Zika virus in human blood has been approved by the U.S. Food and Drug Administration.

The test is called the ZIKV Detect 2.0 IgM Capture ELISA and is made by Seattle-based InBios, which makes tests for other viruses such as West Nile and dengue, CBS News reported. Until now, the only FDA-approved tests for Zika were used to detect virus antibodies and were only for emergency use.

Zika "continues to be a problem in many parts of the world," according to the U.S. Centers for Disease Control and Prevention. There is no vaccine to prevent Zika infection or medicine to treat it.

In the United States, CDC data show that the majority of the 5,600 cases of Zika in 2016 and 2017 occurred in people who traveled to affected areas, but there were 339 mosquito-borne infections in Florida and Texas, CBS News reported.

Explore further

Zika, West Nile cases reported in Alabama

More information: CBS News Article

Copyright © 2019 HealthDay. All rights reserved.

Citation: FDA approves first test for Zika in human blood (2019, May 31) retrieved 7 October 2022 from https://medicalxpress.com/news/2019-05-fda-zika-human-blood.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors